Postdoctoral Fellowship

first_imgA full-time NIH funded postdoctoral position is available in thelaboratory of Dr. A. James Mixson in the Department of Pathology atthe University of Maryland School of Medicine.Our lab has pioneered several developments in the gene therapyfield, including the first group to deliver intravenously tumorsuppressor and antiangiogenic genes with non-viral carriers. Forthe past two decades, we have primarily focused on deliveringtherapeutic genes and siRNA by improving non-viral carriers. Ourresearch team is interested in developing drug and gene deliverycarriers targeting solid tumors. Specifically, we are investigatingseveral histidine-rich carriers of doxorubicin, siRNA targetingoncogenes, and plasmids-expressing tumor suppressor genes to reducebreast cancer growth in a mouse model. These therapeutic agentswill be evaluated alone and in combination with one another toreduce tumor growth. We seek highly motivated and enthusiasticcandidates with excellent interpersonal skills and the ability towork independently and as part of a collaborative team.Required Qualifications· Ph.D. or M.D. or equivalent degree.· Strong background in pharmacology and molecular biology· Excellent writing and communications skills· Work experience with mice and tail vein injections aredesired.UMB is an equal opportunity/affirmative action employer. Allqualified applicants will receive consideration for employmentwithout regard to sex, gender identity, sexual orientation, race,color, religion, national origin, disability, protected Veteranstatus, age, or any other characteristic protected by law orpolicy. We value diversity and how it enriches our academic andscientific community and strive toward cultivating an inclusiveenvironment that supports all employees.Qualifications :A full-time NIH funded postdoctoral position is available in thelaboratory of Dr. A. James Mixson in the Department of Pathology atthe University of Maryland School of Medicine.Our lab has pioneered several developments in the gene therapyfield, including the first group to deliver intravenously tumorsuppressor and antiangiogenic genes with non-viral carriers. Forthe past two decades, we have primarily focused on deliveringtherapeutic genes and siRNA by improving non-viral carriers. Ourresearch team is interested in developing drug and gene deliverycarriers targeting solid tumors. Specifically, we are investigatingseveral histidine-rich carriers of doxorubicin, siRNA targetingoncogenes, and plasmids-expressing tumor suppressor genes to reducebreast cancer growth in a mouse model. These therapeutic agentswill be evaluated alone and in combination with one another toreduce tumor growth. We seek highly motivated and enthusiasticcandidates with excellent interpersonal skills and the ability towork independently and as part of a collaborative team.Required Qualifications· Ph.D. or M.D. or equivalent degree.· Strong background in pharmacology and molecular biology· Excellent writing and communications skills· Work experience with mice and tail vein injections aredesired.UMB is an equal opportunity/affirmative action employer. Allqualified applicants will receive consideration for employmentwithout regard to sex, gender identity, sexual orientation, race,color, religion, national origin, disability, protected Veteranstatus, age, or any other characteristic protected by law orpolicy. We value diversity and how it enriches our academic andscientific community and strive toward cultivating an inclusiveenvironment that supports all employees.last_img read more